Lb Pharmaceuticals Inc · NASDAQ:LBRX
JPMorgan Chase & Co's stake in Lb Pharmaceuticals Inc fell to 4.30% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 13, 2026
JPMorgan Chase & Co's stake in Lb Pharmaceuticals Inc fell to 4.30%, 1,401,790 shares, as a passive investor on Sep 30, 2026. Filed Oct 13, 2026 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 1,401,790
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 4.30% | 1,401,790 |
Source
Related
- Lb Pharmaceuticals Inc
- JPMorgan Chase & Co
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · JPMorgan Chase & Co · May 13, 2026
- Schedule 13G · JPMorgan Chase & Co · Jan 21, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026